Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...
Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=7361 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback